Literature DB >> 22170235

Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.

Takahiro Kiyosue1, Shintaro Kawano, Ryota Matsubara, Yuichi Goto, Mitsuhiro Hirano, Teppei Jinno, Takeshi Toyoshima, Ryoji Kitamura, Kazunari Oobu, Seiji Nakamura.   

Abstract

BACKGROUND: Recent studies have demonstrated that the p75 neurotrophin receptor (p75NTR) is a useful marker of keratinocyte stem cells. Although the stem cell markers of original normal tissue have been used to identify cancer stem cells in a variety of cancers, the expression and function of p75NTR have been poorly understood in oral squamous cell carcinoma (OSCC). The objective of this study is, thus, to examine p75NTR expression immunohistochemically in oral leukoplakia (OL), the most frequent precancerous lesion, and OSCC, and to reveal the usefulness of p75NTR as a marker for undifferentiated cancer cells and a novel prognostic factor for OSCC patients.
METHODS: In this study immunohistochemical expression of p75NTR, Ki-67, cytokeratin (CK) 5, and CK14 was examined in 112 cases of OL and 81 of OSCC. The labeling indices (LIs) of p75NTR and Ki-67 were calculated, and the association of these LIs with histopathologic characteristics was then evaluated.
RESULTS: In the normal oral epithelium and OL, p75NTR was expressed only in the basal layer, and its LI was invariant, irrespective of the extent of epithelial dysplasia. In OSCC, however, p75NTR-LI was significantly increased in association with upgrading of histologic grade and mode of tumor invasion. Furthermore, the prognosis of the high p75NTR-LI group (LI ≥ 53.1%) was poorer than that of the low p75NTR-LI group (LI < 53.1%).
CONCLUSIONS: These results suggest that p75NTR is expressed in undifferentiated cell populations in OL and OSCC. Furthermore, p75NTR is possibly involved in invasion and poor prognosis in OSCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170235     DOI: 10.1007/s10147-011-0358-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  43 in total

1.  Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.

Authors:  S Descamps; R A Toillon; E Adriaenssens; V Pawlowski; S M Cool; V Nurcombe; X Le Bourhis; B Boilly; J P Peyrat; H Hondermarck
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

Review 2.  Nerve growth factor receptors and signaling in breast cancer.

Authors:  Laurent Dollé; Eric Adriaenssens; Ikram El Yazidi-Belkoura; Xuefen Le Bourhis; Victor Nurcombe; Hubert Hondermarck
Journal:  Curr Cancer Drug Targets       Date:  2004-09       Impact factor: 3.428

3.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 4.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model.

Authors:  X Wang; J H Bauer; Y Li; Z Shao; F S Zetoune; E Cattaneo; C Vincenz
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

6.  Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.

Authors:  Fatima Khwaja; Daniel Djakiew
Journal:  Mol Carcinog       Date:  2003-03       Impact factor: 4.784

7.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

8.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

9.  Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro.

Authors:  Tomoyuki Okumura; Yutaka Shimada; Masayuki Imamura; Shigeru Yasumoto
Journal:  Oncogene       Date:  2003-06-26       Impact factor: 9.867

10.  Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor.

Authors:  A Rodríguez-Tébar; G Dechant; R Götz; Y A Barde
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  17 in total

1.  Dormancy activation mechanism of oral cavity cancer stem cells.

Authors:  Xiang Chen; Xin Li; Baohong Zhao; Dehao Shang; Ming Zhong; Chunfu Deng; Xinshan Jia
Journal:  Tumour Biol       Date:  2015-02-27

Review 2.  Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.

Authors:  Elisa Tomellini; Chann Lagadec; Renata Polakowska; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2014-01-31       Impact factor: 9.261

3.  Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ghada Abu Elghanam; Xinyun Su; Younan Liu; Peter J Chauvin; Simon D Tran
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

Review 4.  Drug-Tolerant Persister Cells in Cancer Therapy Resistance.

Authors:  Pavan Kumar Dhanyamraju; Todd D Schell; Shantu Amin; Gavin P Robertson
Journal:  Cancer Res       Date:  2022-07-18       Impact factor: 13.312

5.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

6.  Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.

Authors:  Marcos Custódio; Cibele Pelissari; Thalita Santana; Marília Trierveiler
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-19       Impact factor: 2.503

Review 7.  Neurotrophin signaling in cancer stem cells.

Authors:  Valérie Chopin; Chann Lagadec; Robert-Alain Toillon; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2016-02-17       Impact factor: 9.261

Review 8.  Oral epithelial stem cells in tissue maintenance and disease: the first steps in a long journey.

Authors:  Kyle B Jones; Ophir D Klein
Journal:  Int J Oral Sci       Date:  2013-07-26       Impact factor: 6.344

9.  The spatiotemporal expression and mineralization regulation of p75 neurotrophin receptor in the early tooth development.

Authors:  Manzhu Zhao; Xiujie Wen; Gang Li; Yingxin Ju; Yingying Wang; Zhi Zhou; Jinlin Song
Journal:  Cell Prolif       Date:  2018-10-25       Impact factor: 6.831

10.  Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.

Authors:  Teppei Jinno; Shintaro Kawano; Yasuyuki Maruse; Ryota Matsubara; Yuichi Goto; Taiki Sakamoto; Yuma Hashiguchi; Naoki Kaneko; Hideaki Tanaka; Ryoji Kitamura; Takeshi Toyoshima; Akiko Jinno; Masafumi Moriyama; Kazunari Oobu; Tamotsu Kiyoshima; Seiji Nakamura
Journal:  Oncol Rep       Date:  2015-03-06       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.